Gentaur Monalizumab – Anti-KLRC1 / NKG2A / CD159a Antibody

Recognizes inhibitory receptors on NK and CD8+ T-cells. Used to study immune evasion mechanisms in cancer and viral infection models.

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days